Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3949509 | 0.99 | CCR1 (0.55) | CCR1NR1I2 | |
| SCHEMBL3945236 | 0.89 | CCR1 (0.44) | CCR1NR1I2 | |
| SCHEMBL3645828 | 0.87 | CCR1 (0.58) | CCR1NR1I2 | |
| Hydrochloric Acid SCHEMBL3942169 | 0.83 | CCR1 (0.41) | CCR1 | |
| SCHEMBL11903716 | 0.83 | CCR1 (0.61) | CCR1 | |
| Hydrochloric Acid SCHEMBL3942472 | 0.82 | CCR3 (0.48) | CCR1 | |
| SCHEMBL3943994 | 0.81 | CCR1 (0.57) | CCR1NR1I2 | |
| SCHEMBL3643486 | 0.81 | CCR1 (0.58) | CCR1 | |
| SCHEMBL3940674 | 0.80 | CCR1 (0.58) | CCR1 | |
| SCHEMBL1873951 | 0.79 | CCR1 (0.69) | CCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2486034-A1 | SPIROCYCLIC COMPOUNDS AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Bristol-Myers Squibb Company (US) | 2012-08-15 | — | — | EP | disclosed |
| WO-2011044197-A1 | SPIROCYCLIC COMPOUNDS AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-04-14 | — | — | WO | disclosed |
| EP-2049486-A2 | PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Bristol-Myers Squibb Company (US) | 2009-04-22 | — | — | EP | disclosed |
| WO-2007092681-A2 | PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-08-16 | — | — | WO | disclosed |